Tetra Bio-Pharma Inc. is pleased to provide investors with an update on our research, regulatory and commercial activities after closing the public placement.
Stay up to Date
With our deep technical expertise, innovative approach and proven track-record, we are truly invested in bringing novel drugs and treatments to patients and their healthcare providers.
Stay up-to-date with the latest news and information from Tetra Bio-Pharma, its subsidiaries and its partners by reading press releases, getting the latest updates on product development and finding out about upcoming events.
Register for email alerts and be the first to have Tetra’s news delivered to your inbox.
Tetra Bio-Pharma Inc. is pleased to announce it has closed its previously announced short form prospectus offering of units of the Corporation, including the exercise in full of the Agents’ over-allotment option.
Panag Pharma Receives a Repayable $500,000 Contribution from the Atlantic Canada Opportunities Agency (ACOA)
Tetra Bio-Pharma Inc. is pleased to announce that its wholly owned subsidiary Panag Pharma Inc. has received a repayable Government of Canada contribution of $500,000 through the Atlantic Canada Opportunities Agency’s (ACOA) Business Development Program.
Carol Levine (Energi PR)
Tel: 514.288.8500, ext. 226